Your browser is no longer supported. Please, upgrade your browser.
MLAB Mesa Laboratories, Inc. daily Stock Chart
Mesa Laboratories, Inc.
Index- P/E565.55 EPS (ttm)0.39 Insider Own4.50% Shs Outstand4.37M Perf Week1.42%
Market Cap1.09B Forward P/E49.44 EPS next Y4.45 Insider Trans-8.37% Shs Float4.16M Perf Month-1.04%
Income1.30M PEG- EPS next Q0.76 Inst Own85.90% Short Float10.56% Perf Quarter-2.38%
Sales117.70M P/S9.27 EPS this Y-83.50% Inst Trans2.82% Short Ratio10.02 Perf Half Y-13.18%
Book/sh50.30 P/B4.37 EPS next Y19.30% ROA0.40% Target Price263.67 Perf Year-6.00%
Cash/sh16.41 P/C13.41 EPS next 5Y- ROE0.70% 52W Range181.90 - 271.46 Perf YTD-11.79%
Dividend0.64 P/FCF48.71 EPS past 5Y-34.90% ROI1.50% 52W High-18.96% Beta0.36
Dividend %0.29% Quick Ratio4.20 Sales past 5Y10.50% Gross Margin55.20% 52W Low20.95% ATR8.28
Employees460 Current Ratio4.70 Sales Q/Q29.50% Oper. Margin6.40% RSI (14)48.11 Volatility3.20% 3.31%
OptionableNo Debt/Eq0.64 EPS Q/Q-210.20% Profit Margin1.10% Rel Volume0.95 Prev Close218.14
ShortableYes LT Debt/Eq0.64 Earnings- Payout135.90% Avg Volume43.87K Price220.00
Recom2.00 SMA20-0.12% SMA50-5.64% SMA200-6.95% Volume41,462 Change0.85%
Dec-04-19Initiated Jefferies Buy
Aug-26-19Initiated Evercore ISI Outperform $250
Jun-10-16Downgrade Sidoti Buy → Neutral
Jul-06-20 12:00PM  
Jun-16-20 11:53AM  
Jun-14-20 09:06PM  
Jun-09-20 08:15PM  
Jun-08-20 04:01PM  
Jun-01-20 09:25AM  
May-25-20 12:30PM  
May-15-20 08:00AM  
May-11-20 03:30PM  
Apr-22-20 09:13AM  
Apr-01-20 06:00PM  
Mar-16-20 11:04AM  
Mar-10-20 09:03AM  
Feb-10-20 08:00AM  
Jan-31-20 10:12AM  
Jan-27-20 12:30PM  
Jan-09-20 07:00PM  
Dec-16-19 06:12AM  
Nov-06-19 09:35AM  
Oct-31-19 08:55PM  
Oct-28-19 02:15PM  
Oct-23-19 10:33AM  
Oct-21-19 12:52PM  
Oct-01-19 05:00PM  
Sep-06-19 08:38AM  
Aug-07-19 11:20PM  
Aug-06-19 04:21PM  
Aug-01-19 10:27AM  
Jul-30-19 09:25AM  
Jul-23-19 10:32AM  
Jul-09-19 03:00PM  
Jul-04-19 04:10PM  
Jun-24-19 06:00PM  
Jun-17-19 01:20PM  
Jun-03-19 10:46AM  
May-04-19 09:42PM  
May-03-19 02:04PM  
Apr-08-19 01:44PM  
Mar-18-19 03:10PM  
Mar-06-19 08:00AM  
Feb-08-19 10:00AM  
Feb-04-19 09:20AM  
Jan-28-19 10:30AM  
Jan-08-19 08:00PM  
Jan-02-19 07:00PM  
Dec-25-18 09:31AM  
Dec-03-18 05:00AM  
Nov-30-18 09:15AM  
Nov-29-18 08:00AM  
Oct-31-18 08:39AM  
Oct-22-18 09:25AM  
Oct-11-18 01:57PM  
Oct-02-18 01:00PM  
Sep-27-18 08:43AM  
Sep-25-18 08:42AM  
Sep-21-18 07:28AM  
Jul-31-18 09:27AM  
Jul-30-18 08:06AM  
Jul-09-18 06:00PM  
Jul-02-18 07:50AM  
Jun-05-18 07:53AM  
May-26-18 02:01PM  
Apr-11-18 08:00AM  
Apr-04-18 07:00PM  
Feb-23-18 09:03AM  
Feb-05-18 05:22PM  
Feb-01-18 07:30AM  
Jan-31-18 08:29AM  
Jan-02-18 03:34PM  
Nov-30-17 11:29AM  
Nov-21-17 09:31AM  
Nov-08-17 08:00AM  
Nov-06-17 08:21AM  
Nov-01-17 12:23PM  
Oct-13-17 05:42AM  
Oct-06-17 08:34AM  
Oct-05-17 04:00PM  
Oct-03-17 08:00AM  
Sep-22-17 09:55AM  
Sep-19-17 06:03PM  
Sep-18-17 12:06PM  
Sep-14-17 09:15AM  
Sep-05-17 06:58AM  
Sep-01-17 08:00AM  
Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products in the United States, Canada, Europe, and Japan. The company's Sterilization and Disinfection Control segment manufactures and markets biological indicators comprising spore strips, self-contained products, and culture media, as well as process challenge devices; and offers testing services. This segment also provides chemical and cleaning indicators that are used to assess the effectiveness of sterilization and cleaning processes. Its Instruments segment offers data loggers used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air sampling; and torque testing systems used for measure bottle cap tightness. This segment's products are used in healthcare, pharmaceutical, medical device, food and beverage, industrial hygiene, and environmental air sampling industries. The company's Biopharmaceutical Development segment develops, manufactures, and commercializes automated solutions for protein analysis, which include analysis equipment, CDs, kits, and buffers; and peptide synthesizers to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. Its Continuous Monitoring segment offers systems, which are used to monitor temperature, humidity, and differential pressure for use in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies, and laboratory environments. The company was founded in 1982 and is headquartered in Lakewood, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Archbold Brian DavidSVP Continuous ImprovementJun 15Option Exercise0.00700302Jun 17 12:34 PM
DINOIA GREGORYSVP Commecial OperationsJun 15Option Exercise0.009001,552Jun 17 12:59 PM
Owens Gary MCEOJun 15Option Exercise0.001,000011,440Jun 17 11:59 AM
GUILLEMIN EVANDirectorJun 15Option Exercise0.0030035,878Jun 16 07:33 PM
Schmieder John BradleyDirectorJun 15Option Exercise0.0030073,467Jun 16 07:09 PM
KELLY DAVID MDirectorJun 15Option Exercise0.003002,810Jun 16 06:54 PM
Sullivan John JamesDirectorJun 15Option Exercise0.0030063,731Jun 16 06:13 PM
Dwyer Robert VDirectorApr 03Option Exercise116.1349056,90436,564Apr 03 07:01 PM
Dwyer Robert VDirectorApr 03Option Exercise78.7337829,75936,074Apr 03 06:47 PM
Sullivan John JamesDirectorFeb 27Option Exercise67.843,286222,91373,049Feb 27 07:37 PM
Sullivan John JamesDirectorFeb 27Sale256.021,702435,74671,347Feb 27 07:37 PM
Sullivan John JamesDirectorFeb 26Option Exercise86.161,07092,19472,417Feb 27 06:35 PM
Sullivan John JamesDirectorFeb 26Sale263.391,070281,82771,347Feb 27 06:35 PM
Sullivan John JamesDirectorFeb 25Option Exercise50.868,206417,38179,553Feb 27 06:35 PM
Sullivan John JamesDirectorFeb 25Sale267.098,2062,191,74171,347Feb 27 06:35 PM
Archbold Brian DavidSVP of Continuous ImprovementFeb 21Sale268.1912332,987232Feb 21 05:55 PM
Schmieder John BradleyDirectorFeb 19Sale266.461,800479,62873,437Feb 19 05:53 PM
Dwyer Robert VDirectorFeb 13Sale258.626,1331,586,11635,696Feb 13 05:41 PM
Dwyer Robert VDirectorFeb 12Sale258.721,367353,67041,829Feb 13 05:41 PM
GUILLEMIN EVANDirectorDec 16Sale251.317,5001,884,82540,848Dec 16 07:22 PM
Schmieder John BradleyDirectorNov 25Sale238.06700166,64275,119Nov 26 04:32 PM
Perez David BrianDirectorNov 07Option Exercise0.002750275Nov 07 12:28 PM
Alltoft Jennifer SadieDirectorNov 07Option Exercise0.002090209Nov 07 12:21 PM
GUILLEMIN EVANDirectorNov 07Option Exercise0.00150048,348Nov 07 12:14 PM
Dwyer Robert VDirectorNov 07Option Exercise0.00150057,718Nov 07 12:07 PM
KELLY DAVID MDirectorNov 07Option Exercise0.0015002,780Nov 07 11:22 AM
Sullivan John JamesDirectorNov 07Option Exercise0.00150071,347Nov 07 11:04 AM
Schmieder John BradleyDirectorNov 07Option Exercise0.00150075,819Nov 07 11:51 AM
Owens Gary MPresident and CEOSep 16Option Exercise0.001,720010,440Sep 19 10:05 AM
Sakys JohnCFOSep 03Option Exercise48.721,00048,7203,500Sep 03 12:22 PM